MoonLake Immunotherapeutics (MLTX) Superinvestor holders
15 of the superinvestors we track hold MoonLake Immunotherapeutics (MLTX) in their latest 13F filings, $175M in total.
Summary
The largest holder is David Shaw (D. E. Shaw & Co.), with $66M, 0.0% of the portfolio.
In their latest quarter: 2 opened a new position, 7 added, 5 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| David Shaw D. E. Shaw & Co. |
Added | 3,365,507 | $66M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 1,715,349 | $33M | 0.0% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Trimmed | 1,158,732 | $23M | 0.0% | Q2 2026 |
| Arrowstreet Capital | Added | 750,777 | $15M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Added | 643,268 | $13M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 550,351 | $11M | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 358,884 | $7M | 0.0% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Trimmed | 250,000 | $5M | 0.0% | Q2 2026 |
| Didric Cederholm Lion Point Capital |
Held | 67,500 | $1M | 6.3% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Trimmed | 58,740 | $1M | 0.0% | Q2 2026 |
| Alger Fred Alger Management |
New position | 32,254 | $627,985 | 0.0% | Q2 2026 |
| Ken Tropin Graham Capital Management |
Added | 21,545 | $419,481 | 0.0% | Q2 2026 |
| Man Group Man Group plc |
New position | 17,661 | $343,860 | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Trimmed | 11,221 | $131,000 | 0.0% | Q3 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 3,939 | $76,692 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 15 |
| Q1 2026 | 14 |
| Q4 2025 | 10 |
| Q3 2025 | 6 |
| Q2 2025 | 7 |
| Q1 2025 | 7 |
| Q4 2024 | 6 |
| Q3 2024 | 6 |
Questions about MoonLake Immunotherapeutics
Which superinvestors own MoonLake Immunotherapeutics?
15 of the superinvestors we track hold MoonLake Immunotherapeutics (MLTX) in their latest 13F filings, $175M in total. David Shaw, Two Sigma, Steve Cohen, Arrowstreet Capital, Jim Simons, Paul Marshall.
Who is the largest superinvestor holder of MLTX?
The largest holder is David Shaw (D. E. Shaw & Co.), with $66M, 0.0% of the portfolio.
From MoonLake Immunotherapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.